Acadia Pharmaceuticals Inc

Geneos Wealth Management Inc. ACAD

Report date

9/30/2025

Quarter

2025 Q3

Filed

10/22/2025

1,425

Value ($000)

Weight

0.0%

2016 Q1 - 2025 Q3 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	10/22/2025	30	0.0%	1,425	9/30/2025
2025 Q2	8/18/2025	14	0.0%	669	6/30/2025
2025 Q1	5/8/2025	16	0.0%	0	3/31/2025
2024 Q4	1/21/2025	6	0.0%	335	12/31/2024
2024 Q3	11/14/2024	4	0.0%	278	9/30/2024
2022 Q2	7/22/2022	6	0.0%	450	6/30/2022
2022 Q1	5/16/2022	10	0.0%	450	3/31/2022
2021 Q4	2/9/2022	10	0.0%	450	12/31/2021
2021 Q3	11/9/2021	7	0.0%	450	9/30/2021
2021 Q2	7/8/2021	10	0.0%	450	6/30/2021
2021 Q1	6/17/2021	9	0.0%	450	3/31/2021
2020 Q4	5/19/2021	11	0.0%	450	12/31/2020
2020 Q3	9/7/2021	18	0.0%	450	9/30/2020
2020 Q2	9/7/2021	21	0.0%	450	6/30/2020
2020 Q1	9/7/2021	17	0.0%	450	3/31/2020
2019 Q4	9/7/2021	19	0.0%	450	12/31/2019
2019 Q3	9/7/2021	16	0.0%	450	9/30/2019
2019 Q2	9/7/2021	23	0.0%	867	6/30/2019
2019 Q1	9/7/2021	23	0.0%	867	3/31/2019
2018 Q4	9/7/2021	13	0.0%	867	12/31/2018
2018 Q3	9/7/2021	17	0.0%	867	9/30/2018
2018 Q2	9/7/2021	48	0.0%	3,167	6/30/2018
2018 Q1	9/7/2021	71	0.0%	3,167	3/31/2018
2017 Q4	9/7/2021	4	0.0%	150	12/31/2017
2017 Q1	9/7/2021	2	0.0%	63	3/31/2017
2016 Q4	9/7/2021	1	0.0%	63	12/31/2016
2016 Q3	9/7/2021	2	0.0%	63	9/30/2016
2016 Q1	9/7/2021	28	0.0%	1,000	3/31/2016